Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
According to MarketBeat, BeiGene presently has a consensus rating of Moderate Buy and a consensus target price of $282.
As of this writing, BeiGene shares are trading at around $255 with a 52-week range of $118.18 to $280.62, giving the company a market capitalization of more than $29 billion.
Driehaus Capital Management LLC bought a new position in shares of BeiGene during the 4th quarter valued at approximately $962,000.
Finally, 3M reaffirmed a “downgrade” rating on shares of BeiGene in a research report on Friday, June 30th.
JPMorgan Chase & Co. boosted their target price on BeiGene from $297.00 to $300.00 and gave the stock an “overweight” rating in a research note on Monday, August 7th.
Source: https://www.americanbankingnews.com/2023/08/24/beigene-nasdaqbgne-sees-large-volume-increase.html
Mirae Asset Global Investments Co. Ltd. bought a new stake in shares of BeiGene, Ltd. () during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission.
So right now, we we've controlled that process all the way along for the benefit of our partners, and so we'll be setting up commercial arrangements that allow Wuxi to supply BeiGene and Jazz, directly.